Johny B-131 Oct 2021 06:42
Many thanks to you for all the research you have done here in recent times, and once again for the latest find from the financials which somewhat caused a series of negative posts to cease as one poster who posted 19 times (3 removed), finally run out of posters post to twist and seemingly agree on issues they had never even mentioned nor I dare say could be bothered to defend. I guess there is always somebody very keen to rub as many peoples noses out of joint as possible at the hint of an SP decline. As ever was the case, getting their facts right is the last consideration.
Worth reading the series of posts in question and it highlights from Johny B- 1 All that is good from a BB down to the dangers of any one single persons agenda with total disregard to the facts available. Asa resul tof Johnys research this was posted.................................
AB124
Posts: 908
Price: 19.75
No Opinion
RE: For the avoidance of doubt we have Redmile’s backingSat 08:40
For the sake of clarity I'll post what I should have said in the first place!
Since we now know (thanks to Johnny B1's incisive research) that RM have paid 20.38p for shares that lifts their obligation (should they take their holding over 30% (unlikely) from a takeover at 13p/sh to a new level of 20.38p/sh.
So thanks to our new researcher we can say that there's pretty well a floor on the SP at 20.3p unless the entire edifice of Scancell collapses or RM depart (also unlikely).
This changes my perception of the SP's likely near term level.
A very significant find Johnny B1 and many thanks for sharing!
AIMO
Again many apologies for my error.
Again on Thursday after another series of removed posts by kashdog and yourself directed at me you called for the BB to decide whether I was a liar over whether I sold 40 or 50k shares in February,,..................I have never seen two posters so infactuated in damaging the standing of any poster as you guys are trying to do.
But hey, back in the world of what only matters to me, my investment, I am happy with the extensions to the CLNs if only to make any negotiations for future positons in Scancell less complicated, the Financials IMHO were pretty much in line with my expectations. At least as we know the trial for COVIDITY is underway. i was"t expecting detail of updates covering all platforms, I feel that will form the basis of this years AGM, just surprised perhaps we still haven"t received the notice of AGM which will take place later than any other year.
It is my hope, that the reason for the delay is due to a couple of items of news we are waiting on, ready to report and be able to re assess priorities in Research & Development, new platforms and most importantly getting existing platforms recruited and trials started ASAP.
Sign In
Follow the stocks
